Testimonios de nuestros clientes
Su pedido
€ 0.00 (0 artículos)
Search:
Perform search
Lista de categorías

Genérico Lamivudine - Combivir, Epivir

Nuevo
Búsqueda por letra:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Combivir
El Combivir Genérico está dentro de un grupo de medicamentos llamados inhibidores de la transcriptasa inversa. Se utiliza combinado con otros medicamentos para tratar la infección por VIH.
€ 1.13
Epivir
El Epivir Genérico se utiliza para el tratamiento de la infección por VIH en combinación con otros medicamentos.
€ 1.36
País, idioma y moneda


Garantíade devolución
Comprasegura

Nuestra página de facturación está certificada por:

Secure shopping certificates

Special Offer!

  • Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls

    Zee NewsAurobindo Pharma receives final approval for Lamivudine+Zidovudine TabletsEquity BullsAurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.

  • Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times

    Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement.

  • Aurobindo Pharma receives US FDA approval - Express Pharma

    Aurobindo Pharma receives US FDA approvalExpress PharmaAurobindo Pharma has received final approval from the US FDA to manufacture and market Lamivudine and Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.

  • LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego

    LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.

  • Patent expires of landmark HIV drug Combivir - U-T San Diego

    Patent expires of landmark HIV drug CombivirU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.

    Copyright © www.cajera.com is an affiliate marketing website. Todos los derechos reservados. | Tools fuer Webmaster.